S&P Futures
4,014.75 +10.00 (+0.25%) Dow Futures
32,218.00 +59.00 (+0.18%) Nasdaq Futures
12,293.50 +48.75 (+0.40%) Russell 2000 Futures
1,788.50 +6.10 (+0.34%) Crude Oil
113.85 -0.35 (-0.31%) Gold
1,825.70 +11.70 (+0.64%)
Viveve Medical, Inc. (VIVE)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.7800 |
| Open | 0.7700 |
| Bid | 0.7704 x 1200 |
| Ask | 0.8300 x 1200 |
| Day's Range | 0.7422 - 0.8110 |
| 52 Week Range | 0.7400 - 3.2200 |
| Volume | |
| Avg. Volume | 69,190 |
| Market Cap | 8.377M |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.1330 |
| Earnings Date | Nov 11, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.88 |
- ACCESSWIRE
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
6 million in Q1 including sale of 2,750 consumable treatment tipsPURSUIT trial top-line results anticipated at end of 2022Conference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / May 12, 2022/ Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.
- ACCESSWIRE
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.
- ACCESSWIRE
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growthEnrollment completed in U.
